Ophthalmology

Uzm. Dr. Nilüfer Zorlutuna Kaymak

Doctor and researcher Kartal Dr. Lütfi Kırdar Şehir Hastanesi İstanbul
UveitisEye Infections, BacterialUveitis, AnteriorBehcet Syndrome

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Uveitis 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Eye Infections, Bacterial 2 publications
  • Uveitis, Anterior 2 publications
  • Behcet Syndrome 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyOphthalmologysaglik.gov.trFrom source
  • InstitutionKartal Dr. Lütfi Kırdar Şehir Hastanesisaglik.gov.trFrom source
  • Area of workUveitisExtracted from 7 publications · Model version —From source
  • Publications31 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0002-9673-824XORCIDFrom source
  • Last synchronised5 November 2026 08:56https://lutfikirdareah.saglik.gov.tr/TR-1476845/doktorlarimiz.html#nilufer-zorlutuna-kaymaksaglik.gov.tr

Scientific work

Publications on Uveitis

31 publications
Publications by year Most: 7, in 2026
  1. 2006: 3 publications
  2. 2007: 0 publications
  3. 2008: 0 publications
  4. 2009: 0 publications
  5. 2010: 0 publications
  6. 2011: 0 publications
  7. 2012: 1 publication
  8. 2013: 1 publication
  9. 2014: 1 publication
  10. 2015: 0 publications
  11. 2016: 1 publication
  12. 2017: 0 publications
  13. 2018: 2 publications
  14. 2019: 0 publications
  15. 2020: 3 publications
  16. 2021: 2 publications
  17. 2022: 2 publications
  18. 2023: 3 publications
  19. 2024: 2 publications
  20. 2025: 3 publications
  21. 2026: 7 publications
  1. Rituximab in Refractory Non-Infectious Uveitis, Scleritis, and Idiopathic Orbital Inflammatory Syndrome: A Real-World Single-Centre Retrospective Case Series from Türkiye

    Ocular Immunology and Inflammation, 2026

    DOI 10.1080/09273948.2026.2735420 PMID 42789551 Source: ORCID

  2. Rifampicin-Associated DRESS Syndrome Followed by Rifabutin-Associated Hypopyon Uveitis in an Immunocompetent Patient with Mycobacterium Kansasii Infection

    Ocular Immunology and Inflammation, 2026

    DOI 10.1080/09273948.2026.2689369 PMID 42287414 Source: ORCID

  3. Diagnostic and therapeutic impact of PCR in uveitis: real-world data from intraocular fluid analysis of 45 uveitis patients in a tertiary referral center in Turkey

    BMC Ophthalmology, 2026

    DOI 10.1186/s12886-026-05002-5 PMID 42332605 Open-access full textSource: ORCID

  4. Neuro-Behçet’s Syndrome Developing During Follow-Up for Behçet Uveitis: A Tertiary Uveitis Center Experience

    Ocular Immunology and Inflammation, 2026

    DOI 10.1080/09273948.2026.2667772 PMID 42082456 Source: ORCID

  5. Evaluation of family physicians' knowledge, awareness, attitudes, behaviors and practice patterns regarding neonatal vision screening

    European eye research, 2026

    DOI 10.14744/eer.2026.63325 Open-access full textSource: OpenAlex

  6. Syphilitic Uveitis in HIV-Positive and -Negative Patients: A Multicenter Cohort Study

    Turkish journal of ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.39267 PMID 42037575 Open-access full textSource: Europe PMC

  7. Pars plana vitrectomy in uveitis of diverse etiologies: indications and surgical outcomes

    BMC Ophthalmology, 2026

    DOI 10.1186/s12886-026-05162-4 PMID 42661186 Open-access full textSource: OpenAlex

  8. Artificial intelligence in predicting macular hole surgery outcomes: a focus on optical coherence tomography parameters

    BMC Ophthalmology, 2025

    DOI 10.1186/s12886-025-04256-9 PMID 40696275 2 citations (Europe PMC) Open-access full textSource: ORCID

  9. Outcomes of Eye Examination and Vision Screening in Term Infants Presenting to a Tertiary Hospital in Türkiye

    Turkish journal of ophthalmology, 2025

    DOI 10.4274/tjo.galenos.2025.07572 PMID 40272145 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  10. Real-World Efficacy and Safety of Escalation to Weekly Adalimumab for Chronic Non-Infectious Uveitis: A Multicenter Study Involving Pediatric and Adult Patients

    Ocular Immunology and Inflammation, 2025

    DOI 10.1080/09273948.2025.2456637 PMID 39868489 4 citations (Europe PMC) Source: ORCID

View all 31 publications